GENEAIDYX IS GOING OUT OF BUSINESS AS ON 1/31/2020. NO SAMPLES WILL BE PROCESSED IF RECEIVED AFTER 1/17/2020. THANK YOU ALL FOR YOUR YEARS OF DEDICATION IN IDENTIFYING INDIVIDUALS WITH ALPHA-1 ANTITRYPSIN DEFICIENCY.
The GeneAidyx Mission
To improve the lives of individuals with alpha-1-antitrypsin deficiency and their families through research & development & service by:
- Removing significant impediments to research by developing shared resources
- Developing and utilizing cutting edge technologies to improve the early identification of individuals with alpha-1-antitrypsin deficiency